Company Analysis

PolyPid Ltd. (PYPD)

Nasdaq: PYPD · Surgical & Medical Instruments & Apparatus · Petach Tikva, IL · filing with the SEC since 2014
Grade5.0
◀ Past 5.3● Present 4.0▶ Future 6.0
7 est.
The companyfiscal 2025, as filed
Revenuen/a
Net income-$34.2M-17.7%
Earnings per share$2.09-57.4%
Operating cash flow-$27.9M-26.9%
Cash$6.6M-58.3%
Debtn/a
Shareholders’ equity$11.0M+42.8%
Shares, diluted16.4M+176.5%
Return on equity-311.4%
The recordfrom its filings
Filings in 202644
Newest filingNov 12 · 6-K
Annual reportFeb 25, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted12
Filer categoryNon-accelerated filer
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
1819202122232425
As filed, in USD. Nothing here is a forecast.

News

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton PYPD · research, not advice